MEM Non-Essential Amino Acids Solution (100X)
MEM Non-Essential Amino Acids Solution (100X)
Gibco™

MEM Non-Essential Amino Acids Solution (100X)

Gibco™ MEM Non-Essential Amino Acids are used as a supplement for cell culture medium, to increase cell growth and viability.
製品番号(カタログ番号)数量
1114007620 x 100 mL
11140050100 mL
製品番号(カタログ番号) 11140076
価格(JPY)
117,500
Each
お問い合わせください ›
数量:
20 x 100 mL

Gibco™ MEM Non-Essential Amino Acids are used as a supplement for cell culture medium, to increase cell growth and viability. Gibco™ MEM Non-Essential Amino Acids contains the same non-essential amino acids found in the standard Minimum Essential Medium (MEM) at a strength of 100X. The complete formulation is available.

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.
仕様
細胞タイプMammalian Cells
濃度100X
製造品質cGMP-compliant under the ISO 13485 standard
数量20 x 100 mL
品質保持期間18 Months
形状Liquid
製品タイプAmino Acid Supplement
無菌性Sterile-filtered
pH0.9
Unit SizeEach
組成および保存条件
Store at 2–8°C. Protect from light.

よくあるご質問(FAQ)

Where can I find the formulation of MEM Non-Essential Amino Acids Solution (100X) (Cat. No. 11140050)?

The formulation of MEM Non-Essential Amino Acids Solution (100X) can be found at this link: https://www.thermofisher.com/us/en/home/technical-resources/media-formulation.165.html

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What is the solvent used for MEM Non-Essential Amino Acids Solution (100X)?

The solvent is distilled water.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What is Gibco MEM Non-Essential Amino Acids?

MEM Non-Essential Amino Acids are used as a supplement for cell culture medium, to increase cell growth and viability. MEM Non-Essential Amino Acids contains the same non-essential amino acids found in the standard Minimum Essential Medium (MEM) at a strength of 100X. The complete formulation is available here (http://www.thermofisher.com/us/en/home/technical-resources/media-formulation.165.html).

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

引用および参考文献 (4)

引用および参考文献
Abstract
Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Authors:Mueller Cornelius; Baudler Stephanie; Welzel Hilke; Böhm Michael; Nickenig Georg;
Journal:Circulation
PubMed ID:12021231
BACKGROUND: Reactive oxygen species, such as superoxide (O(2)(-)), are involved in the abnormal growth of various cell types. Angiotensin II (Ang II) is one of the most potent inducers of oxidative stress in the vasculature. The molecular events involved in Ang II-induced proliferation of vascular smooth muscle cells (VSMCs) are ... More
Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis.
Authors: Ylänne J; Huuskonen J; O'Toole T E; Ginsberg M H; Virtanen I; Gahmberg C G;
Journal:J Biol Chem
PubMed ID:7721884
'The cytoplasmic domain of the beta subunit of the alpha IIb beta 3 integrin is required for cell spreading on fibrinogen. Here we report that deletion of six amino acids from the COOH terminus of the beta 3 (I757TYRGT) totally abolished cell spreading and formation of adhesion plaques, whereas retaining ... More
Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells.
Authors:Zhang J, Nuebel E, Wisidagama DR, Setoguchi K, Hong JS, Van Horn CM, Imam SS, Vergnes L, Malone CS, Koehler CM, Teitell MA,
Journal:Nat Protoc
PubMed ID:22576106
Measurements of glycolysis and mitochondrial function are required to quantify energy metabolism in a wide variety of cellular contexts. In human pluripotent stem cells (hPSCs) and their differentiated progeny, this analysis can be challenging because of the unique cell properties, growth conditions and expense required to maintain these cell types. ... More
Reprogramming human fibroblasts to pluripotency using modified mRNA.
Authors:Mandal PK, Rossi DJ,
Journal:Nat Protoc
PubMed ID:23429718
Induced pluripotent stem (iPS) cells hold the potential to revolutionize regenerative medicine through their capacity to generate cells of diverse lineages for future patient-specific cell-based therapies. To facilitate the transition of iPS cells to clinical practice, a variety of technologies have been developed for transgene-free pluripotency reprogramming. We recently reported ... More